Evidence map›Paper›PMID 26961159›Full record

ArticleScientific reports2016

Carnosic acid slows photoreceptor degeneration in the Pde6b(rd10) mouse model of retinitis pigmentosa.

Kai Kang, Matthew J Tarchick, Xiaoshan Yu, Craig Beight, Ping Bu, Minzhong Yu

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 26 papers.

0numbers the graph read from it
0cells of the map it votes in
26citing papers in PubMed
6.4field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

26 citing papers in PubMed, 60 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Review
  7. Article
  8. Current Strategies and Potential Prospects for Nanoparticle-Mediated Treatment of Diabetic Nephropathy.Diabetes, metabolic syndrome and obesity : targets and therapy · 2022
    Review
  9. Article
  10. Article
  11. Review
  12. Article
  13. Article
  14. Rod Photoreceptor Neuroprotection in Dark-Reared Pde6brd10 Mice.Investigative ophthalmology & visual science · 2020
    Article
  15. Article
  16. Article
  17. Review
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 4 institutions in 1 country.

Kai KangDepartment of Ophthalmic Research, Cole Eye Institute, Cleveland Clinic Foundation, Cleveland OH, USA.
Matthew J TarchickDepartment of Ophthalmic Research, Cole Eye Institute, Cleveland Clinic Foundation, Cleveland OH, USA.
Xiaoshan YuDepartment of Ophthalmic Research, Cole Eye Institute, Cleveland Clinic Foundation, Cleveland OH, USA.
Craig BeightDepartment of Ophthalmic Research, Cole Eye Institute, Cleveland Clinic Foundation, Cleveland OH, USA.
Ping BuDepartment of Ophthalmology, Loyola University Chicago, Maywood, IL, USA.
Minzhong YuDepartment of Ophthalmic Research, Cole Eye Institute, Cleveland Clinic Foundation, Cleveland OH, USA.
Cleveland Eye Clinic · USCleveland Clinic · USLouis Stokes Cleveland VA Medical Center · USLoyola University Chicago · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The photoreceptor cell death associated with the various genetic forms of retinitis pigmentosa (RP) is currently untreatable and leads to partial or complete vision loss. Carnosic acid (CA) upregulates endogenous antioxidant enzymes and has proven neuroprotective in studies of neurodegenerative models affecting the brain. In this study, we examined the potential effect of CA on photoreceptor death in the Pde6b(rd10) mouse model of RP. Our data shows that CA provided morphological and functional preservation of photoreceptors. CA appears to exert its neuroprotective effects through inhibition of oxidative stress and endoplasmic reticulum stress.

Indexed as

AbietanesAnimalsAntioxidantsCyclic Nucleotide Phosphodiesterases, Type 6Endoplasmic Reticulum StressMiceMice, Inbred C57BLNeuroprotective AgentsPhotoreceptor CellsRetinitis PigmentosaAbietanesAntioxidantsCyclic Nucleotide Phosphodiesterases, Type 6Neuroprotective AgentsPde6b protein, mousesalvin

Identifiers

PMID26961159
PMCPMC4785376
OpenAlexW2295027129

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.